FR 180204,
FR-180204,
FR180204,
865362-74-9,
FR 180204,
FR180204,
FR-180204,
ERK Inhibitor II, FR180204,
5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine,
5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE,
CHEMBL259551,
C18H13N7,
5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-2H-pyrazolo[3,4-c]pyridazin-3-amine,
5-{2-phenylpyrazolo[1,5-a]pyridin-3-yl}-1H-pyrazolo[3,4-c]pyridazin-3-amine,
5-{2-phenylpyrazolo[1,5-a]pyridin-3-yl}-2H-pyrazolo[3,4-c]pyridazin-3-amine,
ERK inhibitor II,
MLS002607685,
MLS006010291,
GTPL5966,
SCHEMBL1801785,
SCHEMBL15017777,
CHEBI:91383,
CTK8E9484,
AOB6420,
DTXSID30693489,
HMS3229G06,
HMS3678B05,
BCP09857,
EX-A1490,
BDBM50229978,
MFCD14585805,
s7524,
ZINC28565323,
AKOS015994542,
AKOS026750281,
CCG-206837,
CS-3270,
DB07794,
EE-0007,
SB19430,
KS-0000183V,
NCGC00183912-01,
NCGC00183912-09,
BC600488,
HY-12275,
QC-11788,
SMR001522560,
SMR004701360,
FK-180204,
FT-0709131,
SW218212-2,
Y1888,
J3.509.348F,
A14119,
FR180204, >=98% (HPLC),
BRD-K68756823-001-03-0,
3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-7H-pyrazolo[3,4-c]pyridazin-5-amine,
5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3 -ylamine,
5-(2-phenylH-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine,
D0ZG4G,
XVECMUKVOMUNLE-UHFFFAOYSA-N,
CID11493598,
CID 11493598,
A8304,
C505241,
1H-Pyrazolo[3,4-c]pyridazin-3-amine, 5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-,
FR 180204, 98%, a potent and selective ATP-competitive inhibitor of ERK - 25MG 25mg,
FR1802045-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylaMine,
1177970-73-8,